Word

Status

Dead

Status Code

404

Status Date

Tuesday, January 4, 2022

Serial Number

79108413

Registration Number

4311029

Registration Date

Tuesday, April 2, 2013

Mark Type

2000

Filing Date

Tuesday, January 3, 2012

Published for Opposition

Tuesday, January 15, 2013

Cancellation Date

Tuesday, January 4, 2022

Trademark Owner History

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. - Original Registrant
SHENZHEN SALUBRIS; PHARMACEUTICALS CO.,LTD. - Owner At Publication

Classifications

5 Medicines for human purpose, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Pharmaceutical preparations, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Chemico-pharmaceutical preparations, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Capsules for pharmaceutical purposes, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Raw material drug, namely, active pharmaceutical ingredients which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system,digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Chinese medicine nostrum, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Biochemical medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Dietetic substances adapted for medical use, beverages or food which are used for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Additives to fodder for medical use; Medicines for veterinary purposes, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system,digestive system and endocrine system, for the treatment of infective diseases,for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases for use in veterinary

The mark consists of an abstract incomplete circle.
Color is not claimed as a feature of the mark.

Trademark Events

Jul 23, 2022

Notification Of Effect Of Cancellation Of Intl Reg Mailed

Jul 23, 2022

Death Of International Registration

Sep 12, 2020

Total Invalidation Processed By The Ib

Aug 16, 2020

Generic Madrid Transaction Sent To Ib

Aug 15, 2020

Generic Madrid Transaction Created

Jul 8, 2020

Total Invalidation Of Reg Ext Protection Created

Nov 8, 2019

Cancelled Section 71

Oct 8, 2019

Correction From The Ib Examined, No Action Is Needed

Jul 5, 2019

Correction Transaction Received From Ib

Jul 4, 2019

New Representative At Ib Received

Dec 7, 2018

New Representative At Ib Received

Aug 7, 2014

New Representative At Ib Received

Jul 20, 2013

Final Decision Transaction Processed By Ib

Jul 3, 2013

Final Disposition Notice Sent To Ib

Jul 3, 2013

Final Disposition Processed

Jul 2, 2013

Final Disposition Notice Created, To Be Sent To Ib

Apr 2, 2013

Registered-Principal Register

Feb 20, 2013

Notification Processed By Ib

Jan 15, 2013

Published For Opposition

Dec 26, 2012

Notification Of Possible Opposition Sent To Ib

Dec 26, 2012

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Dec 26, 2012

Notice Of Publication

Dec 10, 2012

Law Office Publication Review Completed

Dec 10, 2012

Assigned To Lie

Nov 26, 2012

Approved For Pub - Principal Register

Oct 31, 2012

Teas/Email Correspondence Entered

Oct 30, 2012

Correspondence Received In Law Office

Oct 30, 2012

Teas Response To Office Action Received

Jul 1, 2012

Refusal Processed By Ib

Jun 8, 2012

Non-Final Action Mailed - Refusal Sent To Ib

Jun 8, 2012

Refusal Processed By Mpu

Jun 8, 2012

Non-Final Action (Ib Refusal) Prepared For Review

Jun 7, 2012

Non-Final Action Written

Apr 6, 2012

Assigned To Examiner

Feb 14, 2012

Application Filing Receipt Mailed

Feb 10, 2012

New Application Office Supplied Data Entered In Tram

Feb 9, 2012

Sn Assigned For Sect 66a Appl From Ib